Capstone Therapeutics (NASDAQ:CAPS – Get Free Report) and Transcat (NASDAQ:TRNS – Get Free Report) are both small-cap industrials companies, but which is the better investment? Get Capstone Therapeutics alerts:Institutional & Insider Ownership2.5% of Capstone Therapeutics shares are held by institutional investors. ProfitabilityNet Margins Return on Equity Return on Assets Capstone Therapeutics -41.26% -114.15% -39.74% Transcat 0.99% 5.56% 3.44%Analyst RatingsThis table compares Capstone Therapeutics and Transcat’s net margins, return on equity and return on assets. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Capstone Therapeutics $48.11 million 0.09 -$21.23 million ($3.37) -0.08 Transcat $331.88 million 2.63 $5.38 million $0.37 251.65Transcat has higher revenue and earnings than Capstone Therapeutics. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010.